DexCom, Inc. Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
21.2%projected annual EPS growth
Analyst Coverage
25analysts covering
FY Revenue (est.)
$5.2Bnext fiscal year
FY EPS (est.)
$2.66next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Next Earnings Release | 29 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Quarterly reported revenue growth, year over year (%) Quarterly13.0%Target: FY2026 guidance: 11%-13% growth and $5.18-$5.25 billion of revenue
Quarterly non-GAAP operating margin (%) Quarterly25.1%Target: FY2026 guidance: 23.5%-24.0%
Watch Items
- Durability of organic revenue growth relative to Dexcom's long-range growth framework
- Potential reduction in FY2026 revenue guidance
Research as of 29 Aug 2026